Why the study?
Do angiotensin II receptor blockers prevent complications from atrial fibrillation?
Do angiotensin II receptor blockers prevent complications from atrial fibrillation?
Answers are grounded in this paper and cite their sources.
Angiotensin II receptor blockers may have potential value in treating atrial fibrillation and preventing its complications by modulating atrial electrical and structural remodeling.
Atrial fibrillation (AF) is the most common form of cardiac arrhythmia and is associated with an increased risk of cardiovascular morbidity and mortality, especially due to ischemic stroke. The occurrence of AF leads to atrial electrical and structural remodeling. The renin-angiotensin system appears to play a role in the development of atrial arrhythmias by its involvement in both of these processes. Large-scale hypertension trials and heart failure trials have indicated the potential value of angiotensin II receptor blockers in the treatment of AF.
No takes yet. Share an insight, caveat, or question.
A 2009 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: